Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
68.88
-1.14 (-1.63%)
Aug 13, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $3.02 billion as of August 13, 2026. Its market cap has increased by 39.41% in one year.
Market Cap
3.02B
Enterprise Value
2.66B
1-Year Change
39.41%
Ranking
Category
Stock Price
$68.88
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $3.02B, an increase of 880.92%. That is a compound annual growth rate of 47.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 3.02B | -13.04% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NewAmsterdam Pharma Company | 3.34B |
| Alumis | 3.30B |
| Arcutis Biotherapeutics | 3.28B |
| MBX Biosciences | 3.23B |
| Disc Medicine | 3.16B |
| uniQure | 3.13B |
| Immunome | 3.11B |
| AbCellera Biologics | 3.04B |